T/Giorgis Abeba
Department of Ophthalmology, Addis Ababa University.
Ethiop Med J. 2012 Apr;50(2):159-65.
In Ethiopia, it is not uncommon to encounter refractory glaucoma cases that could be managed with tube-shunt surgery. Tube-shunt implant surgery has been a standard procedure option and widely used for various forms of refractory glaucoma.
To described the initial experience and outcome of Ahmed Tube shunt implant for refractory adult Ethiopian glaucoma cases.
Retrospective review of consecutive adult patients with refractory glaucoma who underwent Ahmed glaucoma valve implant at the Department of ophthalmology, Menelik II Hospital, Addis Ababa between April 2009 and December 2010.
intraocular pressure (IOP), visual acuity, use of supplemental medical therapy and surgical complications. Success was defined as IOP greater than 5 and less than 22 mmHg with at least 30% reduction in IOP from preoperative levels with and without supplemental glaucoma medications, no additional surgeries to lower the IOP and without visual loss of light perception from devastating postoperative complications.
Thirteen eyes of 12 patients (10 men, 2 women; mean age 52.4 +/- 15. 7) who underwent glaucoma tube-shunt drainage surgery with Ahmed-tube valve were included in this analysis. The mean preoperative IOP was 31.38 +/- 8.67 mmHg with 2.23 +/- 0.44 antiglaucoma medications. Postoperatively, the mean IOP reduced to 15.52 +/- 8.80 mmHg at 1 week, 14.77 +/- 6.39 mmHg at 1 month, 16.62 +/- 4.48 mmHg at 3 months, and 17.15 +/- 3.87 mmHg at 6 months. The reduction from the preoperative mean IOP at last follow up was 45.3% with 1.08 +/- 0.44 supplemental glaucoma medications. The success rate of IOP controlling according to the definition was 76.9%. The pressure remained below 18 mmHg with and without medication in 9/13 (69.2%) eyes, while three eyes required no medication at all till the last follow-up with sustained IOP < 15 mmHg. At the last follow-up the visual acuity reduced by > or = 2 lines in two eyes while one patient's vision worsened from counting finger of one meter to hand movement. Visual improvement of one and two lines documented in two eyes. Hypotony, Tube-corneal touch, acceleration of cataract, choroidal effusion, flat anterior chamber, visual reduction and tube exposure were the types of complications encountered in 6 eyes, while 3 eyes had more than one complication.
The study has shown that tube-shunt implant to be effective in lowering intraocular pressure in refractory glaucoma cases. The few cases reported are indicators of the importance of the procedure in salvaging vision of patients with refractory glaucoma and the need of large scale prospective study in the country.
在埃塞俄比亚,遇到可通过引流管分流手术治疗的难治性青光眼病例并不罕见。引流管分流植入手术一直是一种标准的手术选择,并广泛应用于各种形式的难治性青光眼。
描述艾哈迈德引流管植入术治疗埃塞俄比亚成年难治性青光眼病例的初步经验和结果。
回顾性分析2009年4月至2010年12月在亚的斯亚贝巴梅内利克二世医院眼科接受艾哈迈德青光眼引流阀植入术的连续性成年难治性青光眼患者。
眼压(IOP)、视力、辅助药物治疗的使用情况及手术并发症。成功定义为眼压大于5 mmHg且小于22 mmHg,无论有无辅助青光眼药物治疗,眼压均较术前水平降低至少30%,无需额外手术降低眼压,且无因严重术后并发症导致的光感视力丧失。
本分析纳入了12例患者(10例男性,2例女性;平均年龄52.4±15.7岁)的13只眼,这些患者接受了带艾哈迈德引流管的青光眼引流管分流手术。术前平均眼压为31.38±8.67 mmHg,使用2.23±0.44种抗青光眼药物。术后,1周时平均眼压降至15.52±8.80 mmHg,1个月时为14.77±6.39 mmHg,3个月时为16.62±4.48 mmHg,6个月时为17.15±3.87 mmHg。末次随访时较术前平均眼压降低了45.3%,使用1.08±0.44种辅助青光眼药物。根据定义,眼压控制成功率为76.9%。9/13(69.2%)只眼无论用药与否眼压均保持在18 mmHg以下,3只眼直至末次随访均无需用药,眼压持续<15 mmHg。末次随访时,2只眼视力下降≥2行,1例患者视力从1米指数降至手动。2只眼记录到视力提高1行和2行。低眼压、引流管-角膜接触、白内障加速、脉络膜渗漏(脉络膜脱离)、无前房、视力下降和引流管外露是6只眼中出现的并发症类型,3只眼有不止一种并发症。
该研究表明,引流管分流植入术在降低难治性青光眼病例的眼压方面是有效的。所报告的少数病例表明该手术在挽救难治性青光眼患者视力方面的重要性,以及该国开展大规模前瞻性研究的必要性。